Xarelto Lawsuits Continue As FDA Approved Label Changes Adding More The Blood Thinner Side-Effects, Reports Wright & Schulte LLC

Print

Wright & Schulte Continues To Investigate Xarelto Lawsuits Filed In The U.S. District Court, Eastern District of Louisiana Alleging The Blood Thinner Caused Serve Uncontrolled Bleeding.

xarelto-bleeding-lawsuits-Wright-and-Schulte-LLCAs pretrial proceedings move forward for Xarelto bleeding lawsuits, Wright & Schulte LLC reports that the U.S. Food and Drug Administration (FDA) has approved changes to the drug safety label of Xarelto tablets. The revisions on the blood thinner’s label included adding the term, “thrombocytopenia,” a blood and lymphatic system disorder, as an “Adverse Reaction.” The label also included replacing the Adverse Reaction term “cytolytic hepatitis” with “hepatitis (including hepatocellular injury).” According to prescribing information for the Xarelto blood thinner medication, it is not always possible to estimate how frequently these disorders occur or establish a causal relationship to drug exposure because reporting adverse reactions is voluntary, The most common adverse reaction of Xarelto blood thinner medication is bleeding, according to the label.
[accessdata.fda.gov/drugsatfda_docs/label/2014/022406s015lbl.pdf, December 2014][fda.gov/Safety/MedWatch/SafetyInformation/ucm367392.htm, December 2014]

Xarelto, generically known as rivaroxaban, is an oral blood thinner approved by the FDA to treat blood clots in the leg (deep vein thrombosis) and lungs (pulmonary embolism), and to reduce the risk of stroke and blood clots in patients with atrial fibrillation (irregular heart rhythms). The FDA considerers Xarelto a new generation blood thinner compared to warfarin (Coumadin, Jantoven) the federal agency approved 60 years ago. Warfarin has vitamin K as an antidote should severe bleeding occur but Xarelto does not have an antidote to reverse the effects of the anticoagulant, according to the FDA. In addition to uncontrollable bleeding, other Xarelto side-effects include:

  • Headaches
  • Dizziness
  • Weakness
  • Bright red or black stools (looks like tar)
  • Red, pink, or brown urine
  • Coughing up blood or blood clots
  • [fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm326654.htm, November 2, 2012] [fda.gov/Drugs/NewsEvents/ucm405148.htm, July 17, 2014]
    [xarelto-us.com]

    The attorneys at Wright & Schulte LLC continue to investigate Xarelto side-effects and offers free legal consultation to people who believe they have experienced uncontrollable bleeding and hemorrhaging as a result of using Xarelto and other blood thinners. To speak with one of the firm experienced attorneys call 1-800-399-0795 or you can visit yourlegalhelp.com for more information on this and other prescription drug lawsuits.

    Court records in the Xarelto lawsuit claims indicate that severe bleeding is the most common adverse reaction mentioned in Xarelto lawsuits filed against Bayer AG, Xarelto’s Germany-based manufacturer, and Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals Inc., which markets Xarelto. Due to the growing number of Xarelto lawsuit filings, a panel of federal judges in December transferred 21 federally filed Xarelto complaints to the U.S. District Court, Eastern District of Louisiana. The judicial panel consolidated the Xarelto bleeding side-effects claims in the Louisiana court for coordinated pretrial proceedings. In consolidating the Xarelto cases, the judicial panel explained that the lawsuits had common allegations such as the defendants’ failure to warn doctors, patients and consumers about the fatal bleedings risks associated with the anticoagulant and that there is no antidote should severe bleeding occur in those who take the oral blood thinner. There are 86 cases pending in the litigation as of January 15. (In re: Xarelto (Rivaroxaban) Products Liability Litigation, MDL 2592).

    Records further show that another Xarelto bleeding-lawsuit complaint was filed recently against Bayer, Janssen Pharmaceuticals and its parent company, Johnson & Johnson. The Xarelto blood thinner complaint was filed on behalf of a man who starting taking the anticoagulant in January 2014 and was hospitalized in February 2014 after suffering a “severe gastrointestinal bleed” allegedly as a result of taking Xarelto. In addition to bleeding, the complaint says the man experienced “dizziness, weakness and fatigue accompanied by black, tarry stools.” According to the Xarelto lawsuit, the man had several blood transfusions as a result of the bleeding disorder in which he suffered pain and emotional distress. The Xarelto complaint contends that the defendants were negligent for concealing the Xarelto side effects from the medical community and the public. The lawsuit was filed December 1, 2014 in the U. S. District Court, Eastern District of Louisiana. (Case No. 2:14-cv-02720)

    About Wright & Schulte LLC

    Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you or your loved one suffered serious internal bleeding or other related complications as a result of using Xarelto, contact the law firm for a free, no-obligation legal consultation. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today through yourlegalhelp.com or by calling 1-800-399-0795.

    Contact:
    Wright & Schulte LLC
    865 S. Dixie Dr.
    Vandalia, Ohio 45377
    1-800-399-0795
    http://www.yourlegalhelp.com

This entry was posted in Wright & Schulte Lawsuit News. Bookmark the permalink.